Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP498497.RAmUF3uXtxX3Fyq2rGuYyMcVn-wNRjH3aVgzsDnWrv_V0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP498497.RAmUF3uXtxX3Fyq2rGuYyMcVn-wNRjH3aVgzsDnWrv_V0130_assertion type Assertion NP498497.RAmUF3uXtxX3Fyq2rGuYyMcVn-wNRjH3aVgzsDnWrv_V0130_head.
- NP498497.RAmUF3uXtxX3Fyq2rGuYyMcVn-wNRjH3aVgzsDnWrv_V0130_assertion description "[Interestingly, the p15INK4B gene was frequently methylated in patients with high-risk MDS (refractory anemia with excess blasts [RAEB], RAEB in transformation [RAEB-t], and overt leukemia evolved from MDS; 14/18 [78%]) compared with patients with low-risk MDS (refractory anemia [RA] and refractory anemia with ring sideroblast [RARS]; 1/12 [8%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP498497.RAmUF3uXtxX3Fyq2rGuYyMcVn-wNRjH3aVgzsDnWrv_V0130_provenance.
- NP498497.RAmUF3uXtxX3Fyq2rGuYyMcVn-wNRjH3aVgzsDnWrv_V0130_assertion evidence source_evidence_literature NP498497.RAmUF3uXtxX3Fyq2rGuYyMcVn-wNRjH3aVgzsDnWrv_V0130_provenance.
- NP498497.RAmUF3uXtxX3Fyq2rGuYyMcVn-wNRjH3aVgzsDnWrv_V0130_assertion SIO_000772 9269757 NP498497.RAmUF3uXtxX3Fyq2rGuYyMcVn-wNRjH3aVgzsDnWrv_V0130_provenance.
- NP498497.RAmUF3uXtxX3Fyq2rGuYyMcVn-wNRjH3aVgzsDnWrv_V0130_assertion wasDerivedFrom befree-20140225 NP498497.RAmUF3uXtxX3Fyq2rGuYyMcVn-wNRjH3aVgzsDnWrv_V0130_provenance.
- NP498497.RAmUF3uXtxX3Fyq2rGuYyMcVn-wNRjH3aVgzsDnWrv_V0130_assertion wasGeneratedBy ECO_0000203 NP498497.RAmUF3uXtxX3Fyq2rGuYyMcVn-wNRjH3aVgzsDnWrv_V0130_provenance.